Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1951 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.92 USD | -1.85% | -2.39% | +0.25% | +33.45% | 2.05 B USD | ||
| 1958 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 19.85 USD | +0.30% | +11.14% | +24.92% | +4.75% | 2.10 B USD | ||
| 1960 |  SION Sionna Therapeutics, Inc. - Common Stock | 43.69 USD | -2.76% | +4.20% | +34.10% | +11.06% | 1.97 B USD | ||
| 1972 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 19.50 USD | -4.74% | +2.63% | +22.18% | -13.14% | 2.01 B USD | ||
| 1977 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.32 USD | -4.43% | -4.66% | +33.33% | +106.37% | 1.97 B USD | ||
| 1997 |  ATAI AtaiBeckley Inc. - Common Stock | 5.09 USD | -1.93% | -2.30% | +32.90% | +28.86% | 1.87 B USD | ||
| 1999 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.71 USD | -3.97% | -2.37% | +7.67% | +160.34% | 1.97 B USD | ||
| 2000 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.30 USD | -6.91% | -2.51% | +38.73% | +95.98% | 1.86 B USD | ||
| 2002 |  ZYME Zymeworks Inc. - Common Stock | 26.03 USD | -2.58% | +2.40% | +6.64% | +46.73% | 1.90 B USD | ||
| 2008 |  PGEN Precigen, Inc. - Common Stock | 5.48 USD | -0.54% | -1.44% | +49.73% | +214.94% | 1.95 B USD | ||
| 2009 |  ANAB AnaptysBio, Inc. - Common Stock | 64.91 USD | -3.59% | -2.45% | +24.54% | +84.40% | 1.89 B USD | ||
| 2018 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.43 USD | -4.07% | -3.06% | +31.55% | +149.71% | 1.94 B USD | ||
| 2021 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.65 USD | -4.95% | -0.82% | +9.61% | -33.03% | 1.93 B USD | ||
| 2022 |  TYRA Tyra Biosciences, Inc. - Common Stock | 31.59 USD | -1.10% | +4.60% | +15.97% | +120.29% | 1.88 B USD | ||
| 2029 |  NUVB Nuvation Bio Inc. Class A Common Stock | 5.51 USD | -2.82% | +1.29% | +8.46% | +157.48% | 1.92 B USD | ||
| 2039 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.22 USD | -2.99% | +5.24% | +3.18% | +133.15% | 1.88 B USD | ||
| 2041 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 6.29 USD | -3.23% | -5.84% | +14.16% | +155.69% | 1.81 B USD | ||
| 2054 |  NBTX Nanobiotix S.A. - ADSs | 38.35 USD | -1.16% | -1.29% | +8.12% | +619.51% | 1.86 B USD | ||
| 2061 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 37.03 USD | -1.91% | -2.76% | +32.34% | +94.89% | 1.80 B USD | ||
| 2074 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 26.62 USD | -3.83% | -3.97% | +49.63% | +0.60% | 1.68 B USD |
Notícias Biotechnology Stocks
BofA mantém recomendação de compra para Beam Therapeutics após decisão arbitral
Dinamarca - Ações fecharam o pregão em queda e o Índice OMX Copenhagen 20 recuou 1,33%
‘Por que a CVM não viu isso antes?’
Por que as ações da Beam Therapeutics estão caindo hoje?
Por que as ações da Prime Medicine estão disparando hoje?
Ação da Incyte atinge máxima de 52 semanas em US$ 118,77
Ações da Prime Medicine disparam após vitória em arbitragem contra a Beam
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |